In early studies, no systemic defects were observed in patients with HD [142], however, in a small post-mortem study using three brains of human AD patients, a reduction of EAAT2 mRNA was found in the neostriatum and the degree of reduction correlated with disease progression. Here, SLC1A2 is linked to Huntington disease.